Back to
Cubist Systematic Strategies, LLC
ARQT
Showing 3 of 17 quarters
Position history for
Cubist Systematic Strategies, LLC's holdings in Arcutis Biotherapeutics, Inc.
As of its last 13F, for Q3 2025, Cubist Systematic Strategies held 66,080 shares of ARQT (Arcutis Biotherapeutics), worth $1.2M. It opened the position in Q3 2025.
Current Value
$1.2M
Current Shares
66,080
Total Value Change
-$540,873
Total Shares Change
-62,168
Quarter-by-Quarter History